Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation

Liver Transplantation

Volumn 15, Issue SUPPL. 2, 2009, Pages

  Duclos Vallee, Jean Charles ^a,b,c   Sebagh, Myléne ^a,b,c  

^a HÔPITAL PAUL BROUSSE   (France)

^b Universite Paris Sud   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; IMMUNOSUPPRESSIVE AGENT; MITOCHONDRION ANTIBODY; STEROID;

AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CHOLANGIOGRAPHY; GRAFT RECIPIENT; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER FAILURE; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RECURRENT DISEASE; STEROID THERAPY; BILIARY CIRRHOSIS; PATHOLOGY; REVIEW; RISK FACTOR; SCLEROSING CHOLANGITIS;

CHOLANGITIS, SCLEROSING; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RISK FACTORS;

EID: 77449142384     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21916     Document Type: Article

References (50)

1. Adam R, McMaster P, O'Grady JG, Castaing D, Klempnauer JL, Jamieson N, et al. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl 2003; 9: 1231-1243. (Pubitemid 37536793)
2. Lerut J, Demetris AJ, Stieber AC, Marsh JW, Gordon RD, Esquivel CO, et al. Intrahepatic bile duct strictures after human orthotopic liver transplantation. Recurrence of primary sclerosing cholangitis or unusual presentation of allograft rejection? Transpl Int 1988; 1: 127-130.
3. Graziadei IW,. Recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2002; 8: 575-581. (Pubitemid 34752702)
4. Vera A, Moledina S, Gunson B, Hubscher S, Mirza D, Olliff S, Neuberger J,. Risk factors for recurrence of primary sclerosing cholangitis of liver allograft. Lancet 2002; 360: 1943-1944. (Pubitemid 35472138)
5. Khettry U, Keaveny A, Goldar-Najafi A, Lewis WD, Pomfret EA, Pomposelli JJ, et al. Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study. Hum Pathol 2003; 34: 1127-1136. (Pubitemid 37466998)
6. Kugelmas M, Spiegelman P, Osgood MJ, Young DA, Trotter JF, Steinberg T, et al. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2003; 9: 727-732. (Pubitemid 36874461)
7. Brandsaeter B, Schrumpf E, Bentdal O, Brabrand K, Smith HJ, Abildgaard A, et al. Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors. Liver Transpl 2005; 11: 1361-1369. (Pubitemid 43071585)
8. Campsen J, Zimmerman MA, Trotter JF, Wachs M, Bak T, Steinberg T, Kam I,. Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course. Liver Transpl 2008; 14: 181-185. (Pubitemid 351267274)
9. Alexander J, Lord JD, Yeh MM, Cuevas C, Bakthavatsalam R, Kowdley KV,. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2008; 14: 245-251. (Pubitemid 351267284)
10. Cholongitas E, Shusang V, Papatheodoridis GV, Marelli L, Manousou P, Rolando N, et al. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2008; 14: 138-143. (Pubitemid 351267268)
11. Alabraba E, Nightingale P, Gunson B, Hubscher S, Olliff S, Mirza D, Neuberger J,. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Liver Transpl 2009; 15: 330-340.
12. Graziadei IW, Wiesner RH, Marotta PJ, Porayko MK, Hay JE, Charlton MR, et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 1999; 30: 1121-1127. (Pubitemid 29510847)
13. Jeyarajah DR, Netto GJ, Lee SP, Testa G, Abbasoglu O, Husberg BS, et al. Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process? Transplantation 1998; 66: 1300-1306. (Pubitemid 28551009)
14. Demetris A, Adams D, Bellamy C, Blakolmer K, Clouston A, Dhillon AP, et al. Update of the international Banff schema for liver allograft rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An international panel. Hepatology 2000; 31: 792-799. (Pubitemid 30118655)
15. Boberg KM, Spurkland A, Rocca G, Egeland T, Saarinen S, Mitchell S, et al. The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis. Scand J Gastroenterol 2001; 36: 886-890. (Pubitemid 32656566)
16. Charatcharoenwitthaya P, Lindor KD,. Recurrence of primary sclerosing cholangitis: what do we learn from several transplant centers? Liver Transpl 2008; 14: 130-132. (Pubitemid 351267265)
17. Tinmouth J, Tomlinson G, Heathcote EJ, Lilly L,. Benefit of transplantation in primary biliary cirrhosis between 1985-1997. Transplantation 2002; 73: 224-227. (Pubitemid 34112844)
18. Neuberger J, Portmann B, Macdougall BR, Calne RY, Williams R,. Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med 1982; 306: 1-4. (Pubitemid 12194228)
19. Esquivel CO, Van Thiel DH, Demetris AJ, Bernardos A, Iwatsuki S, Markus B, et al. Transplantation for primary biliary cirrhosis. Gastroenterology 1988; 94: 1207-1216.
20. Polson RJ, Portmann B, Neuberger J, Calne RY, Williams R,. Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis. Clinical and histologic follow-up studies. Gastroenterology 1989; 97: 715-725. (Pubitemid 19205145)
21. Balan V, Batts KP, Porayko MK, Krom RA, Ludwig J, Wiesner RH,. Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation. Hepatology 1993; 18: 1392-1398. (Pubitemid 23348427)
22. Wong PY, Portmann B, O'Grady JG, Devlin JJ, Hegarty JE, Tan KC, Williams R,. Recurrence of primary biliary cirrhosis after liver transplantation following FK506-based immunosuppression. J Hepatol 1993; 17: 284-287. (Pubitemid 23134922)
23. Hubscher SG, Elias E, Buckels JA, Mayer AD, McMaster P, Neuberger JM,. Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation. J Hepatol 1993; 18: 173-184. (Pubitemid 23246944)
24. Gouw AS, Haagsma EB, Manns M, Klompmaker IJ, Slooff MJ, Gerber MA,. Is there recurrence of primary biliary cirrhosis after liver transplantation? A clinicopathologic study in long-term survivors. J Hepatol 1994; 20: 500-507. (Pubitemid 24146365)
25. Lerut JP, Zimmermann A, Gertsch P,. Late graft dysfunction after liver transplantation for primary biliary cirrhosis: disease recurrence versus chronic graft rejection. Am J Gastroenterol 1994; 89: 1896-1898. (Pubitemid 24320568)
26. Dmitrewski J, Hubscher SG, Mayer AD, Neuberger JM,. Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression. J Hepatol 1996; 24: 253-257. (Pubitemid 26104879)
27. Knoop M, Bechstein WO, Schrem H, Lobeck H, Hopf U, Neuhaus P,. Clinical significance of recurrent primary biliary cirrhosis after liver transplantation. Transpl Int 1996; 9 (suppl 1): S115-S119. (Pubitemid 26385694)
28. Van de Water J, Gerson LB, Ferrell LD, Lake JR, Coppel RL, Batts KP, et al. Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis. Hepatology 1996; 24: 1079-1084. (Pubitemid 26365907)
29. Sebagh M, Farges O, Dubel L, Samuel D, Bismuth H, Reynes M,. Histological features predictive of recurrence of primary biliary cirrhosis after liver transplantation. Transplantation 1998; 65: 1328-1333. (Pubitemid 28283094)
30. Hashimoto E, Shimada M, Noguchi S, Taniai M, Tokushige K, Hayashi N, et al. Disease recurrence after living liver transplantation for primary biliary cirrhosis: a clinical and histological follow-up study. Liver Transpl 2001; 7: 588-595. (Pubitemid 32677882)
31. Sanchez EQ, Levy MF, Goldstein RM, Fasola CG, Tillery GW, Netto GJ, et al. The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation. Transplantation 2003; 76: 1583-1588. (Pubitemid 37549831)
32. Neuberger J, Gunson B, Hubscher S, Nightingale P,. Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation. Liver Transpl 2004; 10: 488-491. (Pubitemid 38443587)
33. Guy JE, Qian P, Lowell JA, Peters MG,. Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant. Liver Transpl 2005; 11: 1252-1257. (Pubitemid 41511940)
34. Jacob DA, Neumann UP, Bahra M, Klupp J, Puhl G, Neuhaus R, Langrehr JM,. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients. Clin Transplant 2006; 20: 211-220.
35. Dubel L, Farges O, Bismuth H, Sebagh M, Homberg JC, Johanet C,. Kinetics of anti-M2 antibodies after liver transplantation for primary biliary cirrhosis. J Hepatol 1995; 23: 674-680. (Pubitemid 26013278)
36. Hirschfield GM, Liu X, Xu C, Lu Y, Xie G, Gu X, et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 2009; 360: 2544-2555.
37. Morioka D, Egawa H, Kasahara M, Jo T, Sakamoto S, Ogura Y, et al. Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis. Liver Transpl 2007; 13: 80-90. (Pubitemid 46099977)
38. Levitsky J, Hart J, Cohen SM, Te HS,. The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation. Liver Transpl 2003; 9: 733-736. (Pubitemid 36874462)
39. Charatcharoenwitthaya P, Pimentel S, Talwalkar JA, Enders FT, Lindor KD, Krom RA, Wiesner RH,. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation. Liver Transpl 2007; 13: 1236-1245. (Pubitemid 47457050)
40. Prados E, Cuervas-Mons V, de la Mata M, Fraga E, Rimola A, Prieto M, et al. Outcome of autoimmune hepatitis after liver transplantation. Transplantation 1998; 66: 1645-1650. (Pubitemid 29034985)
41. Milkiewicz P, Hubscher SG, Skiba G, Hathaway M, Elias E,. Recurrence of autoimmune hepatitis after liver transplantation. Transplantation 1999; 68: 253-256. (Pubitemid 29360286)
42. Ratziu V, Samuel D, Sebagh M, Farges O, Saliba F, Ichai P, et al. Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease. J Hepatol 1999; 30: 131-141. (Pubitemid 29023662)
43. Reich DJ, Fiel I, Guarrera JV, Emre S, Guy SR, Schwartz ME, et al. Liver transplantation for autoimmune hepatitis. Hepatology 2000; 32: 693-700.
44. Ayata G, Gordon FD, Lewis WD, Pomfret E, Pomposelli JJ, Jenkins RL, Khettry U,. Liver transplantation for autoimmune hepatitis: a long-term pathologic study. Hepatology 2000; 32: 185-192. (Pubitemid 30614649)
45. Gonzalez-Koch A, Czaja AJ, Carpenter HA, Roberts SK, Charlton MR, Porayko MK, et al. Recurrent autoimmune hepatitis after orthotopic liver transplantation. Liver Transpl 2001; 7: 302-310. (Pubitemid 32331533)
46. Duclos-Vallee JC, Sebagh M, Rifai K, Johanet C, Ballot E, Guettier C, et al. A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence. Gut 2003; 52: 893-897. (Pubitemid 36613499)
47. Gautam M, Cheruvattath R, Balan V,. Recurrence of autoimmune liver disease after liver transplantation: a systematic review. Liver Transpl 2006; 12: 1813-1824. (Pubitemid 44911808)
48. Jones DE, James OF, Portmann B, Burt AD, Williams R, Hudson M,. Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis. Hepatology 1999; 30: 53-57. (Pubitemid 29300568)
49. Hytiroglou P, Gutierrez JA, Freni M, Odin JA, Stanca CM, Merati S, et al. Recurrence of primary biliary cirrhosis and development of autoimmune hepatitis after liver transplant: a blind histologic study. Hepatol Res 2009; 39: 577-584.
50. Hurtova M, Duclos-Vallee JC, Johanet C, Emile JF, Roque-Afonso AM, Feray C, et al. Successful tacrolimus therapy for a severe recurrence of type 1 autoimmune hepatitis in a liver graft recipient. Liver Transpl 2001; 7: 556-558. (Pubitemid 32547275)